期刊文献+

脂代谢紊乱、超敏C反应蛋白和血管性假性血友病因子与冠状动脉病变相关性研究 被引量:2

Ralation of lipoprotein,high sensitive C-reactive protein and von Willebrand factor to coronary heart disease
下载PDF
导出
摘要 目的:观察脂代谢指标、超敏C反应蛋白(hs-CRP)和血管性假性血友病因子(vWF)与冠状动脉病变的关系及其相关性。方法:经冠状动脉造影证实的急性冠脉综合征(ACS)患者74例,其中急性心肌梗死(AM I)32例,不稳定性心绞痛(UAP)42例,另选23例冠状动脉造影阴性者为对照组,测定其血清总胆固醇(TCHO)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A1(apoA1)、载脂蛋白B(apoB)、hs-CRP和血浆vWF水平。结果:AM I组和UAP组HDL-C和apoA1明显低于对照组、hs-CRP和vWF明显高于对照组。三支血管病变组hs-CRP和vWF明显高于单双支病变组,hs-CRP和vWF与血管病变支数呈正相关。结论:急性冠脉综合征患者HDL-C和apoA1降低、hs-CRP和vWF升高,且hs-CRP和vWF与ACS严重程度相关,可能是ACS发生的危险因素。 Objective:This study is to evaluate the serum lipoprotein, high -sensitivity C -reactive protein (hs -CRP) and yon Willebrand factor(vWF) which is used to predict the clinical severity in patients with acute coronary syndrome(ACS). Methods: total cholesterol (TCHO),triglyceride (TG), high density lipoprotein- cholesterol (HDL- C ), low density lipoprotein- cholesterol (LDL- C) ,apolipoprotein (apoAl) ,apolipoprotein (apoB), hs - CRP and vWF were measured in patients. Combined with coronary angiography, the clinical severity was assessed. Results: HDL - C and apoA1 were all significantly lower in AMI and UAP group, hs - CRP and vWF were all significantly higher in AMI and UAP group compared with control group,but there was no significant difference between AMI and UAP group, hs - CRP and vWF were in direct proportion to the number of injured coronary in patient with ACS. Conclusions: The present study indicates that serum HDL - C, vWF and hs - CRP may be a risk factor of coronary artery disease, vWF and hs - CRP can reflect the clinical severity, and may mark unstable atherosclerotic plaque in patients with coronary heart disease.
出处 《中国民康医学》 2006年第3期108-110,共3页 Medical Journal of Chinese People’s Health
关键词 急性冠脉综合征 冠状动脉造影 血脂代谢 超敏C反应蛋白 血管性假性血友病因子 危险因素 acute coronary syndrome', angiography, yon Willebrand factor, high -sensitivity CRP, risk factors
  • 相关文献

参考文献5

  • 1Nagha Vi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment -strategies: Part 1 [ J ]. Circulation ,2003,108 ( 14 ) : 1664 - 1672.
  • 2Schumacher A, Seljeflot I, Sommervoll L, et al. Increased lecels of endothelial haemostatic markers in patients with coronary heart disease[ J]. Thromb Res,2002,105 ( 1 ) :25 - 31.
  • 3周新.应重视血脂指标的联合监测与综合分析[J].中华检验医学杂志,2005,28(1):8-10. 被引量:63
  • 4Rifai N, Ridker PM. High - sensitivity C - reactive Protein : a novel and promising marker d coronary heart disease [ J ]. Clin Chem,2001,47:403 -411.
  • 5王前,郑磊,曾方银.超敏C-反应蛋白的研究现状及临床应用[J].中华检验医学杂志,2004,27(8):542-544. 被引量:193

二级参考文献5

  • 1Expert Panel on Detection,Evaluation,and Treatment of High Blood Chlesterol in Adules.Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation,And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel Ⅲ). JAMA,2001,285:2486-2497.
  • 2Grundy SM, Cleeman JI, Merz CN, et al . Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation, 2004 , 110:227-239.
  • 3方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 4鄢盛恺.关于临床血脂测定的建议[J].中华检验医学杂志,2003,26(3):182-184. 被引量:148
  • 5周新,鄢盛恺.临床血脂分析的现状与发展[J].中华检验医学杂志,2003,26(7):393-395. 被引量:49

共引文献252

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部